<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(71)</volume><submitter>Li J</submitter><funding>Natural Sciences and Engineering Research Council of Canada</funding><funding>National Research Council Canada</funding><pubmed_abstract>Bis-(3'-5')-cyclic dimeric 2'-deoxy-2'-fluoroguanosine monophosphate (2'-F-c-di-GMP) was synthesized through the modified H-phosphonate chemistry. Oral immunization of C57BL/6 mice with &lt;i>Helicobacter pylori&lt;/i> cell-free sonicate extract adjuvanted with 2'-F-c-di-GMP led to the production of antigen-specific antibodies in feces and sera, and lowered bacterial counts in the stomach upon post-vaccination infections in immunized mice. Similarly, oral vaccination of BALB/c mice with flagillin proteins from &lt;i&gt;Clostridium difficile&lt;/i> and &lt;i>Listeria monocytogenes&lt;/i> adjuvanted with 2'-F-c-di-GMP led to production of antigen-specific antibodies both systemically and mucosally. The adjuvanticity of 2'-F-c-di-GMP is associated with the enhanced induction of interferon γ. These results demonst</pubmed_abstract><journal>RSC advances</journal><pagination>41481-41489</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9076492</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>2'-Fluoro-c-di-GMP as an oral vaccine adjuvant.</pubmed_title><pmcid>PMC9076492</pmcid><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Lee RK</pubmed_authors><pubmed_authors>Chen W</pubmed_authors><pubmed_authors>Yan H</pubmed_authors></additional><is_claimable>false</is_claimable><name>2'-Fluoro-c-di-GMP as an oral vaccine adjuvant.</name><description>Bis-(3'-5')-cyclic dimeric 2'-deoxy-2'-fluoroguanosine monophosphate (2'-F-c-di-GMP) was synthesized through the modified H-phosphonate chemistry. Oral immunization of C57BL/6 mice with &lt;i>Helicobacter pylori&lt;/i> cell-free sonicate extract adjuvanted with 2'-F-c-di-GMP led to the production of antigen-specific antibodies in feces and sera, and lowered bacterial counts in the stomach upon post-vaccination infections in immunized mice. Similarly, oral vaccination of BALB/c mice with flagillin proteins from &lt;i&gt;Clostridium difficile&lt;/i> and &lt;i>Listeria monocytogenes&lt;/i> adjuvanted with 2'-F-c-di-GMP led to production of antigen-specific antibodies both systemically and mucosally. The adjuvanticity of 2'-F-c-di-GMP is associated with the enhanced induction of interferon γ. These results demonst</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Dec</publication><modification>2025-04-04T23:17:16.51Z</modification><creation>2024-10-19T04:03:42.781Z</creation></dates><accession>S-EPMC9076492</accession><cross_references><pubmed>35541605</pubmed><doi>10.1039/c9ra08310c</doi></cross_references></HashMap>